Maynard Ryan D
CIK 0001363984
Chief Financial OfficerDirector
Filings
11
Latest Feb 24, 2026
Issuers covered
3
Showing
11 of 11
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 100% | +43.2% | +48.1% | +63.6% | +17.9% |
| 90 days | 3 | 100% | +55.9% | +58.5% | +64.2% | +45.1% |
| 180 days | 3 | 67% | +47.7% | +74.7% | +80.1% | -11.9% |
| 365 days | 3 | 100% | +66.3% | +73.8% | +95.5% | +29.5% |
Issuers
Companies where Maynard Ryan D has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| IOVA | Iovance Biotherapeutics, Inc. | 7 | Jun 17, 2025 |
| CARA | Cara Therapeutics, Inc. | 3 | Feb 12, 2024 |
| FHTX | Foghorn Therapeutics Inc. | 1 | Feb 24, 2026 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|